InvestorsHub Logo
Followers 38
Posts 5020
Boards Moderated 1
Alias Born 04/25/2010

Re: gimmee greenbacks post# 216626

Tuesday, 02/25/2020 12:47:53 PM

Tuesday, February 25, 2020 12:47:53 PM

Post# of 329924

Really ? LMAO !


Agreed! It's absolutely hilarious that the thousands of relentless posts trumpeting the expected profits from ActiPatch retail sales have completely dried up in the face of OEM licensing. Somewhat the like inevitable '5 year agrictultural' plans the Soviets laid out repeatedly, and all of which spectacularly failed.

What a the chances DJO or a Orthopedic partner or any OEM partner for that matter entering into an exclusive contact with Biel would view favorably Biel giving the technology to a competitor ?


Ask Dell and HP why they both agreed to license and sell INTEL chips and technologies in their systems.......

Comparing Actipatch to acetaminophen in terms of function and marketability ?


Nope - pointing out that a product or technology can be licensed to others while being sold retail by the manufacturer simultaneously.

Conflating “ flying off the shelves “ to using the term “ gizmo “ is not rational analysis.
The term gizmo or gadget to use your word is applied in this context because that is likely what the average uneducated consumer would assume Actipatch to be.


But it was claimed that the ActiPath flew off the shelves at CVS. I didn't refer to the product as a 'gizmo'; your post did. What is a gizmo other than an unremarkable gadget? Of course one can separate the underlying technology from the product. But by all accounts BOTH work, so......you're stating that both can't be sold, either due to contractual arrangements or other reasons, is completely incorrect. It seems you are saying all the value is in the tech, and none in the product. That's interesting considering the years of testimonials here about how wonderful the product is. Wonderful products CAN be marketed and sold - apparently just not by BIEL.